| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $912.0M | +13.6% |
| Cost of Revenue | $133.2M | +8.3% |
| Gross Profit | $778.8M | +14.6% |
| R&D Expense | $103.2M | -9.6% |
| SG&A Expense | $624.6M | +17.9% |
| Operating Income | $51.0M | +41.2% |
| Pre-tax Income | $65.7M | +12.4% |
| Income Tax | -$79.7M | -1712.6% |
| Net Income | $145.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.8M | -30.2% |
| Short-term Investments | $203.5M | -31.1% |
| Accounts Receivable | $119.7M | +28.6% |
| Inventory | $145.3M | +81.3% |
| Current Assets | $583.7M | -7.5% |
| Total Assets | $907.3M | +12.2% |
| Current Liabilities | $96.1M | +8.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $117.0M | -10.2% |
| Capital Expenditures | $38.5M | -1.6% |
| Investing Cash Flow | $21.4M | +119.0% |
| Financing Cash Flow | -$183.4M | -250.1% |
| Free Cash Flow | $78.5M | -13.9% |
| +171.8% |
| EPS (Basic) | $4.95 | +175.0% |
| EPS (Diluted) | $4.89 | +179.4% |
| Total Liabilities |
| $126.2M |
| +6.3% |
| Stockholders' Equity | $781.2M | +13.3% |